Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioasis Technologies Inc (BIOAF)

Bioasis Technologies Inc (BIOAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 16
  • Shares Outstanding, K 79,410
  • Annual Sales, $ 30 K
  • Annual Income, $ -2,360 K
  • EBIT $ -2 M
  • EBITDA $ -2 M
  • 60-Month Beta 0.50
  • Price/Sales 0.08
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/29/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 +100.00%
on 05/21/25
0.0004 -50.00%
on 05/12/25
-0.0002 (-50.00%)
since 02/27/25
3-Month
0.0001 +100.00%
on 05/21/25
0.0004 -50.00%
on 05/12/25
+0.0001 (+100.00%)
since 02/06/25
52-Week
0.0001 +100.00%
on 05/21/25
0.0130 -98.46%
on 07/16/24
-0.0038 (-95.00%)
since 05/31/24

Most Recent Stories

More News
Bioasis Technologies Inc. Announces Stock Option Grants

NEW HAVEN, Conn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a multi-asset rare...

BIOAF : 0.0002 (+100.00%)
BTI.VN : 0.005 (unch)
Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A

NEW HAVEN, Conn., July 29, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a biopharmaceutical...

BIOAF : 0.0002 (+100.00%)
BTI.VN : 0.005 (unch)
Bioasis Acquires Phase 2 Ready Rare Orphan EGF Assets

Phase 2 ready assets transform Bioasis into a clinical stage company with a multi-asset pipeline focused on rare and orphan drug indications Unique...

BIOAF : 0.0002 (+100.00%)
BTI.VN : 0.005 (unch)
Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A

NEW HAVEN, Conn., June 14, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), (the “Company” or “Bioasis”), a...

BIOAF : 0.0002 (+100.00%)
BTI.VN : 0.005 (unch)
Bioasis and Neuramedy Enter into Research Collaboration and License Agreement

NEW HAVEN, CONN., U.S.A., May 10, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC.. (TSXV:BTI.V; OTCQB:BIOAF), (the “Company or “Bioasis”) a...

BIOAF : 0.0002 (+100.00%)
BTI.VN : 0.005 (unch)
Bioasis Enters Into Research Collaboration With Janssen

NEW HAVEN, CONN., U.S.A., April 11, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), (the “Company or “Bioasis”), a...

BIOAF : 0.0002 (+100.00%)
BTI.VN : 0.005 (unch)
Bioasis to Attend and Present at Upcoming Industry Conference

NEW HAVEN, Conn., March 09, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical...

BIOAF : 0.0002 (+100.00%)
BTI.VN : 0.005 (unch)
Bioasis Announces $200,000 Non-Brokered Private Placement

NEW HAVEN, Conn., Feb. 17, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical...

BIOAF : 0.0002 (+100.00%)
BTI.VN : 0.005 (unch)
Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending November 30, 2021

NEW HAVEN, Conn., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a biopharmaceutical...

BIOAF : 0.0002 (+100.00%)
BTI.VN : 0.005 (unch)
Bioasis Announces Annual General Meeting Results

NEW HAVEN, Conn., Dec. 16, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical...

BIOAF : 0.0002 (+100.00%)
BTI.VN : 0.005 (unch)

Business Summary

biOasis Technologies Inc. is a biopharmaceutical company. It is focused on developing and commercializing proprietary pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The Company is engaged in the development of a vector (Transcend) for the transport...

See More

Key Turning Points

3rd Resistance Point 0.0002
2nd Resistance Point 0.0002
1st Resistance Point 0.0002
Last Price 0.0002
1st Support Level 0.0002
2nd Support Level 0.0002
3rd Support Level 0.0002

See More

52-Week High 0.0130
Fibonacci 61.8% 0.0081
Fibonacci 50% 0.0066
Fibonacci 38.2% 0.0050
Last Price 0.0002
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar